Its expression was analysed in peripheral CD4+ T cells, and they found that miR-155 was significantly elevated in AD patient CD4+ T cells compared with healthy subjects, indicating that it may be a useful biomarker of the disease as well [15]. Here, CD4 is linked to Alzheimer disease.